Pasireotide

Pasireotide (SOM230, trade name Signifor) is an orphan drug approved in the U.S. and Europe for the treatment of Cushing's disease and acromegaly in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

单词	Pasireotide
释义	Pasireotide 英语百科 Pasireotide Pasireotide (SOM230, trade name Signifor) is an orphan drug approved in the U.S. and Europe for the treatment of Cushing's disease and acromegaly in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
随便看	cargo piping system cargo plan Cargo plane cargoplane cargo planning Cargo platform cargo pocket cargo pocket jean cargo policy cargo pooling agreement cargo port cargo port brow cargo port of embarkation Cargo preference cargo preference schemes cargo preferential treatment cargo premium cargo pressure control cargo pressure vessel cargo prime mover cargo projector cargo proportion of general average cargo pump cargo pumping arrangement cargo pumping machinery